• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锂盐治疗对精神分裂症核心精神病性症状的影响。

Impact of lithium therapy on core psychotic symptoms of schizophrenia.

作者信息

Zemlan F P, Hirschowitz J, Sautter F J, Garver D L

出版信息

Br J Psychiatry. 1984 Jan;144:64-9. doi: 10.1192/bjp.144.1.64.

DOI:10.1192/bjp.144.1.64
PMID:6419805
Abstract

The authors have previously reported that a sub-group of schizophrenic-like patients respond favorably to lithium therapy: furthermore, psychotic patients who respond to lithium demonstrate appreciable improvement during the first seven days of treatment. The present study investigated which symptoms of schizophrenia improved quickly during lithium treatment. We found that patients who do respond to lithium show significant improvement in the core symptoms of psychosis--hallucinations, delusions and formal thought disorder--during the first seven days of treatment, thus allowing early identification of 88 per cent of schizophrenic patients who ultimately respond to lithium and 91 per cent of those who do not.

摘要

作者此前曾报道,有一类精神分裂症样患者对锂盐治疗反应良好:此外,对锂盐有反应的精神病患者在治疗的前七天内症状有明显改善。本研究调查了锂盐治疗期间精神分裂症的哪些症状改善迅速。我们发现,对锂盐有反应的患者在治疗的前七天内,精神病的核心症状——幻觉、妄想和形式思维障碍——有显著改善,从而能够早期识别出最终对锂盐有反应的88%的精神分裂症患者以及91%无反应的患者。

相似文献

1
Impact of lithium therapy on core psychotic symptoms of schizophrenia.锂盐治疗对精神分裂症核心精神病性症状的影响。
Br J Psychiatry. 1984 Jan;144:64-9. doi: 10.1192/bjp.144.1.64.
2
Treatment of schizoaffective disorders.分裂情感性障碍的治疗
Schizophr Bull. 1984;10(1):30-48. doi: 10.1093/schbul/10.1.30.
3
The Northwick Park "functional" psychosis study: diagnosis and treatment response.诺斯威克公园“功能性”精神病研究:诊断与治疗反应
Lancet. 1988 Jul 16;2(8603):119-25. doi: 10.1016/s0140-6736(88)90682-4.
4
Mood-incongruent versus mood-congruent psychosis: differential antipsychotic response to lithium therapy.心境不和谐与心境和谐性精神病:锂盐治疗的抗精神病药物差异反应
Psychiatry Res. 1984 Apr;11(4):317-28. doi: 10.1016/0165-1781(84)90005-2.
5
Psychosis, lithium-induced antipsychotic response, and seasonality.精神病、锂诱导的抗精神病反应与季节性
Psychiatry Res. 1988 Dec;26(3):279-86. doi: 10.1016/0165-1781(88)90122-9.
6
[Lithium carbonate treatment of schizoaffective psychoses].
Zh Eksp Klin Med. 1979;19(4):54-8.
7
Antipsychotic effect of buprenorphine in schizophrenia.丁丙诺啡对精神分裂症的抗精神病作用。
Am J Psychiatry. 1987 Oct;144(10):1340-2. doi: 10.1176/ajp.144.10.1340.
8
Treatment of mania: a naturalistic study of electroconvulsive therapy versus lithium in 438 patients.躁狂症的治疗:438例患者中电休克治疗与锂盐治疗的自然主义研究。
J Clin Psychiatry. 1987 Apr;48(4):132-9.
9
Lithium treatment in schizophrenia and schizo-affective disorders.
Br J Psychiatry. 1982 Oct;141:387-400. doi: 10.1192/bjp.141.4.387.
10
Treating a psychotic woman with changing symptoms.治疗一位症状不断变化的精神病女性患者。
Hosp Community Psychiatry. 1989 Sep;40(9):905-7. doi: 10.1176/ps.40.9.905.

引用本文的文献

1
Precision medicine for psychotic disorders: objective assessment, risk prediction, and pharmacogenomics.精神障碍的精准医学:客观评估、风险预测和药物基因组学。
Mol Psychiatry. 2024 May;29(5):1528-1549. doi: 10.1038/s41380-024-02433-8. Epub 2024 Feb 8.
2
Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward.糖原合酶激酶-3抑制剂:十年以来中枢神经系统的临床前和临床研究重点
Front Mol Neurosci. 2022 Jan 21;14:792364. doi: 10.3389/fnmol.2021.792364. eCollection 2021.
3
Lithium for schizophrenia.用于治疗精神分裂症的锂盐。
Cochrane Database Syst Rev. 2015 Oct 28;2015(10):CD003834. doi: 10.1002/14651858.CD003834.pub3.
4
State-related functional integration and functional segregation brain networks in schizophrenia.精神分裂症相关的功能整合和功能分离的大脑网络。
Schizophr Res. 2013 Nov;150(2-3):450-8. doi: 10.1016/j.schres.2013.09.016. Epub 2013 Oct 2.
5
Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial.
Psychopharmacology (Berl). 1993;111(3):359-66. doi: 10.1007/BF02244953.
6
The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.卡马西平在精神分裂症和分裂情感性精神病治疗中的应用:综述
J Psychiatry Neurosci. 1992 Mar;17(1):1-14.